EXACT Sciences Corporation | TalkMarkets | Page 2

EXACT Sciences Corporation | TalkMarkets | Page 2

Sign Up
Sign up with:

People who follow this stock (48)

View All

Latest Posts

About This Stock More About This Stock

Exact Sciences Is Going Higher

Article By: Quad 7 Capital

Tuesday, July 30, 2019 12:23 PM EDT

With the merger of Exact Sciences and Genomic Health, investors should be looking for EXAS earnings positive results by the end of 2020. In the meantime, revenue growth continues to be astounding.

In this article: EXAS, GHDX Also: PFE

Triple Play Acquiring Triple Play

Article By: Bespoke Investment Group

Monday, July 29, 2019 1:14 PM EDT

Exact Sciences announced plans today to acquire another health care company, Genomic Health. The two announced that the agreement would combine Exact Sciences with Genomic Health for $72 per share in cash and stock.

In this article: GHDX, EXAS

Exact Sciences Will Acquire Genomic Health In $2.8B Deal

Article By: Benzinga

Monday, July 29, 2019 9:37 AM EDT

Exact Sciences Corp. will acquire Genomic Health, Inc. for $72 per share in a cash and stock transaction valued at $2.8 billion.

In this article: GHDX, EXAS

Stocks For You To Swing-Trade: EXAS, UNM, ROKU

Article By: Ryan Mallory

Wednesday, April 17, 2019 7:35 AM EDT

Take a look at three trading ideas to prep you for the next trading session.

In this article: UNM, EXAS, ROKU

5 Stocks That May Sink The Market, Do Bonds Have A Secret Message

Article By: Michael J. Kramer

Tuesday, February 26, 2019 9:32 AM EDT

US bonds are still very attractive compared to global rates and the spreads for US bonds got too wide and are now reverting to the mean.

In this article: SPY, CAT, HD, EXAS, GS, META

$EXAS

Comments Status Updates

Exact Sciences: Poised For Further Growth

James Dean Samuels • 11/22/2018 6:59:36 PM

Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS

Exact Sciences: Poised For Further Growth

Beating Buffett • 11/9/2018 4:28:18 AM

Article is a good summary and is likely representative of the future for $EXAS.